PROFUSA, INC. Increase (Decrease) in Other Accrued Liabilities
PROFUSA, INC. (PFSA) reported Increase (Decrease) in Other Accrued Liabilities of $277.87 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-12-17.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2024-12-17
- PROFUSA, INC. increase (decrease) in other accrued liabilities for the quarter ending 2024-09-30 was $22.15K, a 120.99% increase year-over-year.
- PROFUSA, INC. increase (decrease) in other accrued liabilities for the quarter ending 2024-06-30 was $90.54K.
- PROFUSA, INC. increase (decrease) in other accrued liabilities for the quarter ending 2024-03-31 was $165.17K, a 1036.85% increase year-over-year.
- PROFUSA, INC. increase (decrease) in other accrued liabilities for the quarter ending 2023-12-31 was $12.07K, a 90.55% decline year-over-year.
- PROFUSA, INC. increase (decrease) in other accrued liabilities for fiscal 2023 was $634.00, a 99.82% decline from fiscal 2022.
- PROFUSA, INC. increase (decrease) in other accrued liabilities for fiscal 2022 was $343.58K.
| Period end | Increase (Decrease) in Other Accrued Liabilities 2 month | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 5 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 8 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|---|---|---|
| 2024-09-30 | $22.15K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | $112.69K derived: sum of 2 quarters · filed 2024-12-17 | $277.87K 10-Q · filed 2024-12-17 | $289.94K derived: sum of 4 quarters · filed 2024-12-17 | |||
| 2024-06-30 | $90.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-15 | $255.72K 10-Q · filed 2024-11-15 | $267.79K derived: sum of 3 quarters · filed 2024-11-15 | $277.81K derived: sum of 4 quarters · filed 2024-12-17 | |||
| 2024-03-31 | $165.17K 10-Q · filed 2024-10-09 | $177.25K derived: sum of 2 quarters · filed 2024-10-09 | $187.27K derived: sum of 3 quarters · filed 2024-12-17 | $151.28K derived: sum of 4 quarters · filed 2024-12-17 | |||
| 2023-12-31 | $12.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $22.09K derived: sum of 2 quarters · filed 2024-12-17 | -$13.89K derived: sum of 3 quarters · filed 2024-12-17 | $634.00 10-K · filed 2024-02-26 | |||
| 2023-09-30 | $10.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | -$25.97K derived: sum of 2 quarters · filed 2024-12-17 | -$11.44K 10-Q · filed 2024-12-17 | $116.24K derived: sum of 4 quarters · filed 2024-12-17 | |||
| 2023-06-30 | -$35.99K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-15 | -$21.46K 10-Q · filed 2024-11-15 | $106.22K derived: sum of 3 quarters · filed 2024-11-15 | $298.30K derived: sum of 4 quarters · filed 2024-11-15 | |||
| 2023-03-31 | $14.53K 10-Q · filed 2024-10-09 | $142.21K derived: sum of 2 quarters · filed 2024-10-09 | $334.29K derived: sum of 3 quarters · filed 2024-10-09 | $377.42K derived: sum of 4 quarters · filed 2024-10-09 | |||
| 2022-12-31 | $127.68K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $319.76K derived: sum of 2 quarters · filed 2024-02-26 | $362.89K derived: sum of 3 quarters · filed 2024-02-26 | $343.58K 10-K · filed 2024-02-26 | |||
| 2022-09-30 | $192.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-20 | $235.21K derived: sum of 2 quarters · filed 2023-11-20 | $215.90K 10-Q · filed 2023-11-20 | ||||
| 2022-06-30 | $43.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $23.82K 10-Q · filed 2023-08-14 | |||||
| 2022-03-31 | -$19.31K 10-Q · filed 2023-05-17 | ||||||
| 2021-12-31 | $21.66K 10-K · filed 2023-03-06 | ||||||
| 2021-09-30 | $338.00 10-Q · filed 2022-11-10 | ||||||
| 2021-06-30 | $338.00 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |